Shares fell more than 66% Monday morning, which analysts suspect is due to investors seeing the data as not competitive with ...
The deal gives Argenx a drug prospect aimed at the protein target CD122, an approach that’s recently gained traction among ...
Capricor shares lost much of their value ahead of a high-stakes advisory committee meeting. Elsewhere, Ying Huang’s resignation extended a stock slide for Legend and AstraZeneca disclosed more ...
Most recently the leader of buzzy startup Tessera Therapeutics, Severino will look to improve the fortunes of a company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results